USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

Author:

Agathanggelou Angelo1,Smith Edward1,Davies Nicholas J.1,Kwok Marwan12,Zlatanou Anastasia1,Oldreive Ceri E.1,Mao Jingwen1,Da Costa David1,Yadollahi Sina1,Perry Tracey1,Kearns Pamela1,Skowronska Anna1,Yates Elliot1,Parry Helen12,Hillmen Peter3,Reverdy Celine4,Delansorne Remi4,Paneesha Shankara5,Pratt Guy12,Moss Paul12,Taylor A. Malcolm R.1,Stewart Grant S.1,Stankovic Tatjana1

Affiliation:

1. Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom;

2. Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom;

3. Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom;

4. Hybrigenics Services, Paris, France; and

5. Heartlands Hospital, Birmingham, United Kingdom

Abstract

Key Points USP7 is overexpressed and regulates HRR in CLL cells. USP7 inhibition is selectively cytotoxic to CLL cells independently of ATM and p53 and synergizes with chemotherapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3